The report US Psoriasis Market and Competitive Landscape Highlights - 2022, provides comprehensive insights into Psoriasis pipeline products, Psoriasis epidemiology, Psoriasis market valuations and forecast, Psoriasis drugs sales and competitive landscape in the US.
The research is classified into seven sections - Psoriasis treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.
The research is classified into seven sections - Psoriasis treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.
Research Scope:
- Psoriasis pipeline: Find out the products in clinical trials for the treatment of Psoriasis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Psoriasis epidemiology: Find out the number of patients diagnosed (prevalence) with Psoriasis in the US
- Psoriasis drugs: Identify key products marketed and prescribed for Psoriasis in the US, including trade name, molecule name, and company
- Psoriasis drugs sales: Find out the sales revenues of Psoriasis drugs in the US
- Psoriasis market valuations: Find out the market size for Psoriasis drugs in 2021 in the US. Find out how the market advanced from 2019 and forecast to 2027
- Psoriasis drugs market share: Find out the market shares for key Psoriasis drugs in the US
Benefits of this Research:
The research helps executives to- Support monitoring and reporting national Psoriasis market analysis and sales trends
- Track competitor drugs sales and market share in the US Psoriasis market
- Track competitive developments in Psoriasis market and present key issues and learnings
- Synthesize insights for Psoriasis market and products to drive business performance
- Answer key business questions about the Psoriasis market
- Evaluate commercial market opportunity assessment, positioning, and segmentation for Psoriasis products
- Supports decision making in R&D to long term marketing strategies
Table of Contents
1) Psoriasis Treatments2) Psoriasis Pipeline
3) US Psoriasis Epidemiology
4) Marketed Drugs for Psoriasis in US
5) US Psoriasis Market Size and Forecast
6) US Psoriasis Products Sales and Forecast
7) US Psoriasis Market Competitive Landscape
8) Methodology
9) Contact us
List of Tables
1. Psoriasis Phase 3 Clinical Trials, 2022
2. Psoriasis Phase 2 Clinical Trials, 2022
3. Psoriasis Phase 1 Clinical Trials, 2022
4. Psoriasis Epidemiology, US, 2021 - 2027
5. Marketed Drugs for Psoriasis, US, 2021
6. Psoriasis Market Size and Forecast ($), US, 2019 - 2027
7. Psoriasis Drugs Sales ($), US, 2019 - 2027
List of Figures
1. Psoriasis Epidemiology, US, 2021 - 2027
2. Psoriasis Market Size and Forecast ($), US, 2019 - 2027
3. Psoriasis Drugs Market Share (%), US, 2021
